Covaxin booster enhances antibody response against COVID variants: Study
The study was conducted in January and the findings were published in the "Journal of Travel Medicine" on 24th March
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
NIV
Bharat Biotech plans Covaxin launch in second quarter of 2021, post requisite approvals
Immediate focus is to conduct Phase 3 trial successfully
COVAXIN from Bharat Biotech gets DCGI approval for Phase I & II Human Clinical Trials
The human trials of this vaccine candidate for COVID-19, indigenously developed in collaboration with ICMR-NIV, will start across…